Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancer Claims Continue Attracting Federal Enforcement Actions

This article was originally published in The Tan Sheet

Executive Summary

Herbal and supplement products allegedly making deceptive cancer cure claims prompted the Federal Trade Commission to file complaints against 11 firms, including five that rejected settlement offers and are contesting the complaints

You may also be interested in...



Regulatory News In Brief

Peanut recalls spread to nutrition bars; Maxam missing supplement manufacturing specs; Amazing Herbs slip on GMPs; FDA finds hygiene errors in Creation’s Garden; Avon, Bioque cosmetics make drug claims; more Regulatory News In Brief.

Regulatory News In Brief

Peanut recalls spread to nutrition bars; Maxam missing supplement manufacturing specs; Amazing Herbs slip on GMPs; FDA finds hygiene errors in Creation’s Garden; Avon, Bioque cosmetics make drug claims; more Regulatory News In Brief.

Herbal Firm Denied Supreme Court Hearing Over Cancer Claim

The Supreme Court will not consider herbal supplement marketer Daniel Chapter One's argument that the right to freedom of religion allows the firm to claim its products cure cancer.

Related Content

Topics

UsernamePublicRestriction

Register

PS102112

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel